Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alpesh Amin

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
American Heart Journal|September 29, 2009
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registryJason N Katz, Joel M Gore, Alpesh Amin, et al.
The Lancet. Haematology|October 9, 2022
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trialSagar Lonial, Rakesh Popat, Cyrille Hulin, et al.
Kidney International Reports|June 10, 2022
Predicting Post-Heart Transplant Composite Renal Outcome Risk in Adults: A Machine Learning Decision ToolMutlu Mete, Mehmet U S Ayvaci, Venkatesh K Ariyamuthu, et al.
BMC Nephrology|September 27, 2025
Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomesMatthew Nguyen, Gayathri Dileep, Samir Patel, et al.
JAMA Network Open|April 24, 2023
Neutralizing Monoclonal Antibody Use and COVID-19 Infection OutcomesNalini Ambrose, Alpesh Amin, Brian Anderson, et al.
Journal of General Internal Medicine|September 15, 2023
The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19Nalini Ambrose, Alpesh Amin, Brian Anderson, et al.
The New England Journal of Medicine|February 15, 2019
Decolonization to Reduce Postdischarge Infection Risk among MRSA CarriersSusan S Huang, Raveena Singh, James A McKinnell, et al.
Eclinicalmedicine|March 28, 2024
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trialSuzana Margareth Lobo, Gaétan Plantefève, Girish Nair, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
American Heart Journal|September 29, 2009
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registryJason N Katz, Joel M Gore, Alpesh Amin, et al.
The Lancet. Haematology|October 9, 2022
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trialSagar Lonial, Rakesh Popat, Cyrille Hulin, et al.
Kidney International Reports|June 10, 2022
Predicting Post-Heart Transplant Composite Renal Outcome Risk in Adults: A Machine Learning Decision ToolMutlu Mete, Mehmet U S Ayvaci, Venkatesh K Ariyamuthu, et al.
BMC Nephrology|September 27, 2025
Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomesMatthew Nguyen, Gayathri Dileep, Samir Patel, et al.
JAMA Network Open|April 24, 2023
Neutralizing Monoclonal Antibody Use and COVID-19 Infection OutcomesNalini Ambrose, Alpesh Amin, Brian Anderson, et al.
Journal of General Internal Medicine|September 15, 2023
The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19Nalini Ambrose, Alpesh Amin, Brian Anderson, et al.
The New England Journal of Medicine|February 15, 2019
Decolonization to Reduce Postdischarge Infection Risk among MRSA CarriersSusan S Huang, Raveena Singh, James A McKinnell, et al.
Eclinicalmedicine|March 28, 2024
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trialSuzana Margareth Lobo, Gaétan Plantefève, Girish Nair, et al.
Pageof 16